Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Maturity-Onset Diabetes of the Young Overview

In: GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993.
.
Affiliations
Free Books & Documents
Review

Maturity-Onset Diabetes of the Young Overview

Rochelle Naylor et al.
Free Books & Documents

Excerpt

The purpose of this overview is to:

  1. 1

    Describe the clinical characteristics of maturity-onset diabetes of the young (MODY);

  2. 2

    Review the genetic causes of MODY;

  3. 3

    Provide an evaluation strategy to identify the genetic cause of MODY in a proband (when possible);

  4. 4

    Inform (when possible) medical management of MODY based on genetic cause;

  5. 5

    Inform risk assessment and surveillance of at-risk relatives for early detection and treatment of MODY.

PubMed Disclaimer

Similar articles

  • Permanent Neonatal Diabetes Mellitus.
    De León DD, Pinney SE. De León DD, et al. 2008 Feb 8 [updated 2024 Nov 14]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2008 Feb 8 [updated 2024 Nov 14]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301620 Free Books & Documents. Review.
  • Screening of Mutations in Maturity-onset Diabetes of the Young-related Genes and RFX6 in Children with Autoantibody-negative Type 1 Diabetes Mellitus.
    Şimşek E, Çilingir O, Şimşek T, Kocagil S, Erzurumluoğlu Gökalp E, Demiral M, Binay C. Şimşek E, et al. J Clin Res Pediatr Endocrinol. 2024 May 31;16(2):137-145. doi: 10.4274/jcrpe.galenos.2023.2023-5-10. Epub 2023 Dec 6. J Clin Res Pediatr Endocrinol. 2024. PMID: 38054414 Free PMC article.
  • A Case of Diabetes Mellitus Type MODY5 as a Feature of 17q12 Deletion Syndrome.
    Yaşar Köstek H, Özgüç Çömlek F, Gürkan H, Özkayın EN, Tütüncüler Kökenli F. Yaşar Köstek H, et al. J Clin Res Pediatr Endocrinol. 2024 May 31;16(2):205-210. doi: 10.4274/jcrpe.galenos.2022.2022-3-2. Epub 2022 Dec 13. J Clin Res Pediatr Endocrinol. 2024. PMID: 36511482 Free PMC article.
  • Current views on etiology, diagnosis, epidemiology and gene therapy of maturity onset diabetes in the young.
    Dzhemileva LU, Zakharova EN, Goncharenko AO, Vorontsova MV, Rumyantsev SA, Mokrysheva NG, Loguinova MY, Chekhonin VP. Dzhemileva LU, et al. Front Endocrinol (Lausanne). 2025 Jan 20;15:1497298. doi: 10.3389/fendo.2024.1497298. eCollection 2024. Front Endocrinol (Lausanne). 2025. PMID: 39902162 Free PMC article. Review.
  • Nonsyndromic Genetic Hyperinsulinism Overview.
    Gillis D. Gillis D. 2003 Aug 19 [updated 2024 Oct 31]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2003 Aug 19 [updated 2024 Oct 31]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301549 Free Books & Documents. Review.

References

    1. Alkorta-Aranburu G, Sukhanova M, Carmody D, Hoffman T, Wysinger L, Keller-Ramey J, Li Z, Johnson AK, Kobiernicki F, Botes S, Fitzpatrick C, Das S, Del Gaudio D. 2016. Improved molecular diagnosis of patients with neonatal diabetes using a combined next-generation sequencing and MS-MLPA approach. J Pediatr Endocrinol Metab. 2016;29:523-31. - PubMed
    1. Bacon S, Kyithar MP, Condron EM, Vizzard N, Burke M, Byrne MM. Prolonged episodes of hypoglycaemia in HNF4A-MODY mutation carriers with IGT. Evidence of persistent hyperinsulinism into early adulthood. Acta Diabetol. 2016a;53:965-72. - PubMed
    1. Bacon S, Kyithar MP, Rizvi SR, Donnelly E, Mccarthy A, Burke M, Colclough K, Ellard S, Byrne MM. Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort. Diabet Med, 2016b;33:976-84. - PubMed
    1. Bacon S, Schmid J, McCarthy A, Edwards J, Fleming A, Kinsley B, Firth R, Byrne B, Gavin C, Byrne MM. The clinical management of hyperglycemia in pregnancy complicated by maturity-onset diabetes of the young. Am J Obstet Gynecol. 2015;213:236.e1-7. - PubMed
    1. Bellanné-Chantelot C, Chauveau D, Gautier JF, Dubois-Laforgue D, Clauin S, Beaufils S, Wilhelm JM, Boitard C, Noël LH, Velho G, Timsit J. Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med. 2004;140:510-7. - PubMed

LinkOut - more resources